Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: S&P Capital IQ Quantitative Report
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

BIOLASE Inc Issues Q4 2012 Revenue Guidance In Line With Analysts' Estimates; Comments On Q4 2012 Net Income Guidance; Issues FY 2012 Revenue Guidance In Line With Analysts' Estimates


Monday, 5 Nov 2012 04:15pm EST 

BIOLASE Inc announced that for the fourth quarter of 2012, it expects net revenue to be approximately $16.5-$17.5 million and expects to generate non-GAAP net income positive. For fiscal 2012, it expects non-GAAP adjusted gross revenue of $55-$58 million which excludes the $1.1 million reduction in net revenue from the inventory re-purchase from Schein during the second quarter of 2012. Therefore, the Company's GAAP revenue guidance, which includes the $1.1 million reduction in net revenue from the inventory re-purchase from Schein during the second quarter of 2012, is effectively $53.9-$56.9 million for fiscal 2012. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $17.9 million and net income of $(0.17) for the fourth quarter of 2012 and revenues of $56.9 million for fiscal 2012. 

Company Quote

1.97
-0.01 -0.51%
11 Jul 2014